Launched Niktimvo in the U.S. in late January, in partnership with Incyte. Niktimvo is approved by the U.S. FDA for the treatment of chronic graft-versus-host disease (GVHD) after failure of at least ...

For patients with relapsed BRCA-mutated ovarian carcinoma, rucaparib produced a median OS of 19.4 months vs 25.4 months with chemotherapy in new findings.

Datroway demonstrated durable antitumor activity and an acceptable safety profile in advanced NSCLC with actionable genomic ...

The addition of brentuximab vedotin to lenalidomide and rituximab extended survival among heavily pretreated patients with ...

Antibody-drug conjugates show distinct safety profiles and improve quality of life in metastatic breast cancer.

Lugano, Switzerland, 24 February 2025 – The ESMO Targeted Anticancer Therapies Congress 2025 will showcase state-of-the-art and the latest advancements in new drug development, with focus on new ...

As temperatures in Hays County plummet below freezing, residents and officials are preparing for severe winter weather ...

Bernstam, MD, discusses updated findings from the phase 1 TROPION-PanTumor01 study of datopotamab deruxtecan-dlnk in heavily ...

City of Springfield snowplow drivers are working nonstop to clear the roads, but even using tons of salt is limited in what they can do.

Flights are being canceled or delayed at Dallas Fort Worth International Airport on Feb. 19 due to weather. Zooming in More ...

In this video, Jennifer A. Woyach, MD, discusses a phase 3 randomized trial comparing pirtobrutinib to idelalisib or bendamustine plus rituximab for chronic lymphocytic leukemia pretreated with Bruton ...

A research team has introduced an innovative solution for the depolymerization of polyethylene terephthalate (PET). This ...